Potential microbial contamination spurs recall of 32 children's medications

The pharmaceutical company King Bio recalled 32 children's medicines Aug. 22 due to microbial contamination, according to a FDA recall notice.

King Bio initiated the recall after discovering a small amount of products tested positive for microbial contamination.

The children's medications are intended to treat a range of common illnesses, such as fever, cough and ear aches. King Bio produced the recalled products between August 2017 and April 2018. They were shipped to distributors and retail stores nationwide between August 2017 and July 2018. 

King Bio sent letters to customers and distributors notifying them of the recall and is arranging for the return and replacement of affected medicines.

No illnesses or illnesses have been reported.

More articles on Pharmacy: 

6 things to know about the EpiPen shortage

The No. 1 issue for biopharma: Public distrust

Medicare could have saved $925M by swapping brand-name combo drugs for generics

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months